Trial intelligence / Profile preview

Cyclosporin A vs Mitomycin C for Pterygium Recurrence

NCT06944132Completed

Sponsor
Benha University
Start
Apr 2024
Primary completion
Sep 2024
Countries
1
01

Overview

Randomised, open-label trial of CyclAGel in pterygium (2 arms), sponsored by Benha University. Primary endpoint: Recurrence rate of pterygium at 6 months. Started Apr 2024; status: completed.

02

Drugs

CyclAGel
03

Conditions

pterygium

Beyond the preview

Go deeper on NCT06944132.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06944132.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call